Credit: Thinkstock. The risk of hematocrit elevation may depend on testosterone therapy's route of administration, according to investigators. A rise in hematocrit levels occurs with 4 months of ...

A follow-up of the T4DM trial in men with prediabetes or recent-onset type 2 diabetes show no further glycemic improvement ...

Men with low testosterone should go for intramuscular rather than transdermal replacement formulations, according to a new clinical practice guideline from the American College of Physicians (ACP). In ...

Injectable testosterone esters and transdermal testosterone gels have generally been assumed to be equally safe and effective forms of testosterone-replacement therapy for male hypogonadism. Now, ...

Please provide your email address to receive an email when new articles are posted on . Testosterone undecanoate injected at 8-week intervals for men with hypogonadism may reduce fluctuations and ...

In the latest addition to the ongoing debate over the safety of testosterone treatment, researchers report no significant increased heart-attack risk in older men treated with an intramuscular form of ...

To assess the effect of testosterone treatment on bone remodelling and density in dieting obese men, 100 obese men aged 53 years (interquartile range 47–60) with a total testosterone level <12 nmol/L ...